Next |
home / stock / pbyi / pbyi message board
Subject | By | Source | When |
---|---|---|---|
Awesome weekly chart | mitcheroo | investorshub | 01/26/2023 1:06:50 AM |
znewcar1: $PBYI 20% v1,3M c4.50 f45,6M H4.60 ML2.08 | znewcar1 | investorshangout | 11/22/2022 4:15:11 AM |
Oh man got caught up on the pump | Roadtojourney | investorshub | 01/12/2022 11:09:49 PM |
Historic short interest: | XenaLives | investorshub | 11/22/2021 2:12:16 PM |
Institutional Shares (Long) 36,969,527 - 90.42% (ex 13D/G) - | XenaLives | investorshub | 11/22/2021 2:10:05 PM |
$PBYI two conferences next week | CHARLIE125 | investorshub | 01/08/2021 9:08:36 AM |
$PBYI | CHARLIE125 | investorshub | 01/07/2021 3:40:43 PM |
$PBYI | CHARLIE125 | investorshub | 12/20/2020 8:53:14 PM |
PBYI | CHARLIE125 | investorshub | 12/19/2020 1:41:52 PM |
PBYI you can see last trade 1.3 billions | CHARLIE125 | investorshub | 12/19/2020 1:39:42 PM |
Historic short interest: | XenaLives | investorshub | 11/25/2020 7:26:02 AM |
Option chain 10/29 and 11/16 | XenaLives | investorshub | 11/16/2020 1:39:14 PM |
Blocks >= 5000 | XenaLives | investorshub | 11/12/2020 3:41:36 PM |
Blocks >= 5000 | XenaLives | investorshub | 10/20/2020 4:44:37 PM |
Blocks >= 5000 | XenaLives | investorshub | 09/16/2020 10:18:50 AM |
Block Trades >= 5000 | XenaLives | investorshub | 08/24/2020 9:07:13 PM |
Historic short interest: | XenaLives | investorshub | 08/20/2020 2:17:14 PM |
Puma Biotech ($PBYI) Tops Q2 Earnings and Revenue Estimates | XenaLives | investorshub | 08/07/2020 3:55:17 PM |
Two form 4's and a strange spike to | XenaLives | investorshub | 08/06/2020 12:24:20 AM |
Pipeline | XenaLives | investorshub | 06/18/2020 12:38:41 PM |
News, Short Squeeze, Breakout and More Instantly...
Puma Biotechnology Inc Company Name:
PBYI Stock Symbol:
NASDAQ Market:
Puma Biotechnology Inc Website:
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company (the Company), has been notified by the U.S. Food and Drug Administration (FDA) that its Investigational New Drug Application (IND) submission has been reviewed, and Puma can proceed with the clinical development of alisertib fo...
Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will attend TD Cowen’s 44 th Annual Health Care Conference, which will be held March 4 – 6, 2024, at the Bosto...